Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2016, Vol. 43 Issue (4): 602-605    DOI: 10.12891/ceog3038.2016
Case Report Previous articles | Next articles
Uterine arteriovenous fistula after perforation during the placement of an intrauterine device – Minimally invasive treatment using uterine artery embolization
W. Kondo1, *(), M. Tessmann Zomer1, F. L. Erzinger2
1Department of Gynecology, Sugisawa Medical Center, Curitiba, Paraná
2Department of Vascular Surgery Instituto da Circulação, Curitiba, Paraná; Marcelino Champagnat Hospital, Curitiba, Paraná (Brazil)
Download:  PDF(486KB)  ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Uterine arteriovenous fistula (AVF) is a rare, but potentially life-threatening condition. Acquired fistulae may occur as a result of trauma or instrumentation, endometrial carcinoma, gestational trophoblastic disease, and intrauterine devices (IUDs). Herein the authors present the case of a 33-year-old woman with a uterine AVF developing after uterine perforation during the placement of a levonorgestrel IUD. The fistula was diagnosed using color Doppler ultrasonography and angiography and the treatment was conducted by minimally invasive approach using uterine artery embolization.
Key words:  Uterine arteriovenous malformation      Arteriovenous fistula      Intrauterine device      Uterine artery embolization     
Published:  10 August 2016     
*Corresponding Author(s):  W. KONDO     E-mail:  williamkondo@yahoo.com

Cite this article: 

W. Kondo, M. Tessmann Zomer, F. L. Erzinger. Uterine arteriovenous fistula after perforation during the placement of an intrauterine device – Minimally invasive treatment using uterine artery embolization. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 602-605.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3038.2016     OR     https://ceog.imrpress.com/EN/Y2016/V43/I4/602

[1] Sevcan Arzu Arinkan, Hilal Serifoglu. The possible association of uterine fibroid formation with copper intrauterine device use: a cross-sectional study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 969-973.
[2] Jun Xiong, Fen Fu, Wei Zhang, Ji Luo, Yuan-Yuan Xu, Lu-Lu Le, Xiao-Ju He. Study on influencing factors and related clinical issues in cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 365-371.
[3] Ja Young Kim, Yun Gyu Song, Chang-Woon Kim, Moon Ok Lee. Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 59-65.
[4] G. Zhu, S.J. Liu, W. Lv. Bilateral borderline ovarian cystadenoma with migration of intrauterine device to right ovary accompanied with endometrial carcinoma in situ: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 781-784.
[5] Y. Akdemir, M. Karadeniz. A psychological factor associated with pain during intrauterine device insertion: emotional reactivity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 335-340.
[6] H. J. Wang, Y. H. Wu, P. S. Huang. Severe pelvic actinomycosis with intrauterine device in situ and abdominal wall involvement treated with medication only: case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 306-308.
[7] Y. Wang, F.Y. Luo, Y.D. Xia, L. Mei, L. Xie, H.X. Liu. Clinical analysis of 211 cases of cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 948-952.
[8] S. Gyroglou, X. Anthoulaki, D. Deuteraiou, A. Chalkidou, B. Manav, G. Galazios, V. Souftas, P. Tsikouras. Amenorrhea incidence among symptomatic premenopausal women with uterine fibroids after uterine artery embolization (UAE). Our experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 618-622.
[9] A. Ciavattini, N. Clemente, S. Morini, M. Fichetti, G. Delli Carpini, R. Candelari. Conservative treatment of ectopic cervical pregnancy with uterine artery embolization and cervical curettage: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 456-458.
[10] A. Rebonato, D. Maiettini, S. Gerli, M. Rossi. Interventional radiology in the management of post-partum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 163-165.
[11] Mi Ju Kim. Uterine artery embolization for symptomatic myoma can cause pyomyoma, acute renal failure, and ischemic heart disease: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 135-137.
[12] S. Kaku, S. Tsuji, T. Ono, F. Kimura, T. Murakami. Successful management of complete placenta previa after intrauterine fetal death in a second-trimester pregnancy by uterine artery embolization: case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 458-460.
[13] L. Xie, Y. Wang, Y.C. Man, F.Y. Luo. Preliminary experience in uterine artery embolization for second trimester pregnancy induced labor with complete placenta previa, placenta implantation, and pernicious placenta previa[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 81-84.
[14] L. Li, J. Li, N. Li, Y. Zhang, X. Feng. Analysis of the reason of abnormal uterine bleeding induced by copper corrosion of IUD Cu[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(6): 883-886.
[15] R. Sparic, J. Dotlic, L. Mirkovic, J. Stamenkovic, B. Kastratovic Kotlica, L. Nejkovic, I. Babovic, A. Malvasi, A. Tinelli. Asymptomatic isthmico-cervical uterine perforation with IUD – our experience and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(6): 896-898.
No Suggested Reading articles found!